PeptidePedia The community reference

USP General Chapter 85: difference between revisions

Diff·revision 11 → 12·23:36, 25 Mar 2025

Difference between revision 11 and revision 12 of USP General Chapter 85. 4 lines changed; the page grew by 689 bytes.

Revision 11 — 15:12, 6 Mar 2025
LOD_Lorcan (talk)
add the reference standard and its traceability
3,581 bytes +130
Revision 12 — 23:36, 25 Mar 2025
TitrationTheo (talk)
add the repeatability figure with the number of injections
4,270 bytes +689
31| Basis of normalisation | Per mg of what — substance, or vial contents? |31| Basis of normalisation | Per mg of what — substance, or vial contents? |
3232
+33A numeric result reported from a gel-clot determination is a category error, since the gel-clot method reports whether a clot formed at a dilution rather than a concentration. Certificates showing a number attributed to a gel-clot method are internally inconsistent — see [[Test report forgery]] for the general treatment of internal consistency.{{r|usp1503}} Where a non-endotoxin pyrogen is at issue, a different chapter applies entirely.{{r|usp151}}
+34
33== References ==35== References ==
34{{reflist}}36{{reflist}}
35<ref name="usp85">United States Pharmacopeia, General Chapter <85>, ''Bacterial Endotoxins Test''.</ref>37<ref name="usp85">United States Pharmacopeia, General Chapter <85>, ''Bacterial Endotoxins Test''.</ref>
36<ref name="usp_general">United States Pharmacopeia, ''General Notices and Requirements'', section 3 (conformance to standards) and the numbering convention for general chapters.</ref>38<ref name="usp_general">United States Pharmacopeia, ''General Notices and Requirements'', section 3 (conformance to standards) and the numbering convention for general chapters.</ref>
+39<ref name="usp1503">United States Pharmacopeia, General Chapter <1503>, ''Quality Attributes of Synthetic Peptide Drug Substances''.</ref>
+40<ref name="usp151">United States Pharmacopeia, General Chapter <151>, ''Pyrogen Test''.</ref>
3741
38== See also ==42== See also ==